EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rationale and design for the Blood Pressure Control Target in Diabetes ( BPROAD ) study

BPROAD Study Group

Journal of Diabetes · 2023-12 · 15 (12) · 1029-1040

DOI: 10.1111/1753-0407.13411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 21.06.2023. Verfasst von BPROAD Study Group. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension, Myocardial Infarction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes and hypertension are major modifiable risk factors for cardiovascular disease. Previous clinical trials have demonstrated that intensive blood pressure reduction lowers the risk of cardiovascular disease and all‐cause mortality compared to standard blood pressure reduction among patients without diabetes. However, optimal levels of blood pressure control in patients with diabetes remain uncertain.

Methods

The Blood Pressure Control Target in Diabetes (BPROAD) study is a multicenter, randomized controlled trial conducted in mainland China. We plan to enroll 12 702 participants aged ≥50 years with type 2 diabetes, an increased cardiovascular risk, and systolic blood pressure ≥130 mm Hg from 150 study centers. Participants are randomly assigned to intensive (a systolic target of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2HypertensionMyocardial InfarctionHumansAntihypertensive AgentsBlood PressureMiddle AgedMulticenter Studies as TopicRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

2型糖尿病blood pressurecardiovascular diseaserandomized controlled trialtype 2 diabetes心血管疾病血压随机对照试验

Substanzen

Antihypertensive Agents

Zitieren

APA

BPROAD Study Group (2023). Rationale and design for the Blood Pressure Control Target in Diabetes ( BPROAD ) study. Journal of Diabetes, 15(12), 1029-1040. https://doi.org/10.1111/1753-0407.13411

Vancouver

BPROAD Study Group. Rationale and design for the Blood Pressure Control Target in Diabetes ( BPROAD ) study. Journal of Diabetes. 2023;15(12):1029-1040. doi:10.1111/1753-0407.13411

BibTeX
@article{BPROADStudyGroup2023,
  author = {BPROAD Study Group, BPROAD Study Group},
  title = {Rationale and design for the Blood Pressure Control Target in Diabetes ( BPROAD ) study},
  journal = {Journal of Diabetes},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {1029--1040},
  doi = {10.1111/1753-0407.13411}
}
Kostenlos starten →